AstraZeneca’s EUR 135 Million Investment in France
On January 21st, 2019, AstraZeneca inaugurated the extension of the group’s industrial site in the city of Dunkirk in Northern France. The launch was attended by Secretary of State to…
Business Solutions is the team of experts at Disneyland Paris, dedicated to organizing large venue events for companies, conferences, and congresses. Disneyland Paris is a unique venue and now the largest all-in-one destination for business tourism in Europe. With its own rail terminal, state-of-the-art congress centers, hotels, restaurants and a huge range of activities on offer, Disneyland Paris offers everything a company may need to make an event an outstanding success! With a staff of 150, Disney Business Solutions has a team of specialists ready to customize any type of event in the various Disneyland Paris venues available for events, including plenary rooms or exhibition areas. With a series of hotels and restaurants nearby, all event attendees are in a close, easily navigable site, also in proximity to the amenities of Disneyland Paris’ two theme parks. The venue is conveniently reached by all modes of transportation including local and regional trains (RER and Eurostar), shuttles from both Charles de Gaulle airport and Orly Airport, as well as a mere 35 minutes drive from Paris.
Contact
+33 160 457 500
Euro Disney Associes S.C.A.
Business Solutions
Boite Postale 112
F-77777 Marne-la-Vallee Cedex 4
On January 21st, 2019, AstraZeneca inaugurated the extension of the group’s industrial site in the city of Dunkirk in Northern France. The launch was attended by Secretary of State to…
Franck Puget, managing director for CSL Behring in France, discusses the blood plasma specialist’s commitment to France, building bridges with public authorities, and regulatory attitudes towards rare disease treatments. …
Guillaume El Glaoui, co-founder and CEO of Laboratoires Majorelle, discusses what spurred the creation of the company, its success of gaining the first reimbursement ever of a condom in France,…
Eric Goupil, CEO of Unither Pharmaceuticals, discusses the company’s development strategy moving forward after the completion of a leveraged buyout in 2017. Additionally, Goupil shares the CDMO’s innovation capabilities as…
Mathilde Lignot-Leloup, director of the French Social Security, provides a fascinating look into the French social system and speaks about its ongoing transformation. She elaborates on change management processes within…
Thierry Hulot, president biopharma of Merck France, explains how France has become more open to diversity, while still needing significant reforms in the healthcare sector to remain competitive. He also…
Pascal Joly, general manager of Medac France, explains how he and his executive team have built the French affiliate from scratch, while highlighting the importance of gaining swift market access…
Guy Maugis, president of the Franco-German Chamber of Commerce and Industry, explains the impact of the Macron government on the attractiveness of France as well as the importance of a…
Philippe Truelle, President of CDM Lavoisier, highlights the financial impact of the EU’s Falsified Medicines Directive (FMD) on SMEs across Europe and explains how France is becoming increasingly attractive to…
Frédéric Collet, president Novartis France and general manager oncology explains the rationale behind Novartis’s consistent investment in France, the current shift in the company’s corporate culture and the main challenges inherent to…
In this exclusive interview, David Loew, executive vice president of Sanofi Pasteur, discusses the future of vaccines in France and the rest of the world, their strategic role in reducing…
Nicolas Bardonnet of Promega France discusses the standout growth of the company on the occasion of its 40th anniversary, collaboration with France’s biotech clusters and the growth drivers of the…
See our Cookie Privacy Policy Here
